ISPOR Announces Its 6th Latin America Conference Plenary Sessions and Speakers

Published Jun 20, 2017

Theme Centered on Driving Better Health Outcomes Through Stakeholder Engagement

Princeton, NJ—June 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the plenary sessions and speakers for its 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil. The conference will examine health system reform and sustainability, patient engagement in health care decision making, drug development, and regulatory issues through the lens of the theme, Driving Better Health Outcomes Through Stakeholder Engagement. Conference Co-Chairs include Stephen Doral Stefani, MD, UNIMED; Marcelo Fonseca, MD, MSc, PhD, Federal University of São Paulo; Rosa María Galindo-Suárez, MHE, Mexican Ministry of Health. The first plenary session, Latin American Health Systems Reform: Opportunities and Challenges, is scheduled for Saturday, 16 September 2017. This session will concentrate on the current status, related challenges, and future opportunities of health systems reform in Latin America as a number of countries in the region work to implement universal health care coverage. The plenary features:
  • Eduardo Gonzalez-Pier, PhD, Distinguished Visiting Fellow, Center for Global Development, Washington D.C. (moderator)
  • Jesús Ancer Rodríguez, MD, Secretary, General Health Council, Mexico City, Mexico
  • Rubén Torres, MD, PhD, Dean, ISALUD University, Buenos Aires, Argentina
  • Mauricio Vargas Fuentes, MD, MSc, University of Costa Rica and Latin America Alliance for Global Health, San Pedro, San Jose, Costa Rica
The second plenary session, The Voice of the Patient: Hearing Their Perspective and Incorporating in the Decision-Making Process, is scheduled for Sunday, 17 September 2017. This session will explore the challenges faced and opportunities available to more effectively bring the patient perspective into health care decision making. The plenary features:
  • Federico Augustovski, MD, MSc, PhD, 2017-2018 ISPOR President-Elect and Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina (moderator)
  • Eleanor Perfetto, RPh, PhD, MS, Senior Vice President, Strategic Initiatives, National Health Council, Washington, DC, USA
  • Migdalia Denis, MA, President, Pulmonary Hypertension Society for Latin America, Board member of International Alliance of Patient Organizations (IAPO), Miami, Florida, USA
  • Aline Silveira Silva, Executive Secretariat of the National Committee for Health Technology Incorporation – CONITEC, Brasilia, Brazil
ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in health care decision making. The ISPOR 6th Latin America Conference will host health care stakeholders from the region, including health ministries and government offices, health technology assessment bodies, public and private payers, researchers and academics, and patients and patient representatives. The conference also features the Society’s renowned Essential HEOR Education Short Course Program offering 8 half-day short courses on 15 September 2017. A variety of issue panels, workshops, forums, educational symposia, podium presentations, and poster presentations will also be featured. Additional information on the conference can be found at: Conference Information | Registration | Short Course Program |Sponsorship | Exhibitors | Press

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB    

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×